Drug factory · FDA FEI 3003911081
Alfasigma Spa
VIA ENRICO FERMI 1, Alanno, Italy
Problems found, fixed voluntarily at FDA's last inspection, Sep 27, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2015: 0 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Rifaximin | Makes it | Salix Pharmaceuticals, Inc. | 65649-303 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 27, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 18, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 3, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: manufacture.